The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Kohl’s shares plunge 15% as retailer gives rough outlook for the year ahead
Kohl’s posted a beat on revenue for the fourth quarter on Tuesday, but issued disappointing guidance for the year ahead.
G-7 leaders gather in Canada for summit overshadowed by Middle East crisis and Trump’s tariffs
The gathering of the world’s top industrialized nations is being overshadowed by a widening war across the Middle East and an unresolved trade war.
Mortgage demand drops further, even as interest rates settle
Mortgage rates didn’t move last week, but demand for new home loans continued to weaken.